Pathogenic germline variants associated with different HER2 expression among breast cancer patients
Discover Oncology · 2026-04-27
Combining multiplexed assays of variant effect for enhanced BRCA2 variant classification
Nature Communications · 2026-04-09 · 1 citations
Genetic cancer risk knowledge among Mexican pathogenic variant carriers
Patient Education and Counseling · 2026-02-09
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.
Apollo (University of Cambridge) · 2026-01-09
Data from Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional <i>TP53</i> Status
2025-11-26
Supplementary Figure from Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional <i>TP53</i> Status
2025-11-26
Supplementary Data from Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics
2025-11-24
Supplementary Materials, Figure S1-S4, Table S1-S9 from Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51C
2025-11-24
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer
The Breast · 2025-10-30 · 1 citations
BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes
The American Journal of Human Genetics · 2025-10-30 · 1 citations
Pathogenic Variants, Family History, and Cumulative Risk of Breast Cancer in US Women
JAMA Oncology · 2025-10-09 · 6 citations
Genetic and Cellular Architecture of Breast Cancer Risk Across AncestriesPreprint
medRxiv · 2025-08-24 · 1 citations
Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women
Nature Communications · 2025-08-21 · 3 citations
Pathogenic germline variants in breast cancer patients associated with different HER2 expression levels.
Journal of Clinical Oncology · 2025-05-28
Analysis of BRCA1, BRCA2 and PALB2 related Fanconi anemia identifies scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes
Utrecht University Repository (Utrecht University) · 2025-05-26
Analysis of <i>BRCA1</i> , <i>BRCA2</i> and <i>PALB2</i> related Fanconi anemia identifies scope to expand disease phenotypic features and predict breast cancer risk in heterozygotesPreprint
medRxiv · 2025-05-26 · 1 citations
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification
Nature Communications · 2025-05-24 · 8 citations
Association of gene variant type and location with breast cancer risk in the general population
Annals of Oncology · 2025-04-25 · 7 citations
Abstract 2282: Genetic architecture of breast cancer across diverse populations: Assessing heritability, genetic correlation, and polygenicity
Cancer Research · 2025-04-21
Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial
JCO Oncology Practice · 2025-04-10 · 3 citations